How have head and neck cancer clinical trials been impacted by telemedicine? Watch as expert Dr. Samantha Tam from Henry Ford Health System provides her perspective on scenarios when telemedicine can improve clinical trial access and how care disparities can be changed through the use of telemedicine access.
Samantha Tam, MD, FRCSC, MPH:
While I don’t have specific data on how clinical trial participation has been impacted through telemedicine, I believe that the impact would be several ways, one is that patients that might not be able to access in-person care at a certain center may be introduced to an interesting clinical trial and therefore seek care at a specific center based on that clinical trial, but also there may be patients that might not be able to access the clinical trial because they have not been able to access in-person care at those centers. My current research is not so much in the clinical trials realm, but more exploratory currently, and looking at how we can empower communities that may be at an disadvantage to access telemedicine and virtual care, especially in these times when all institutions have been moving more towards using technology in their delivery of care, so as to ensure that patients are not left behind just because of their potential disadvantages.